The FDA granted Breakthrough Therapy status to zovegalisib plus Faslodex for patients with PIK3CA-mutated HR+/HER2- advanced breast cancer. The U.S. Food and Drug Administration (FDA) has granted ...

Phase 3 trial data show datopotamab deruxtecan reduces the risk of disease progression or death in patients with metastatic TNBC.

Inside a cancer research laboratory on the campus of Harvard Medical School, two dozen small jars with pink plastic lids sat on a metal counter. Inside these humble-looking jars is the core of Joan ...

FDA orphan designation for zenocutuzumab‑zbco targets NRG1 fusion–positive advanced cholangiocarcinoma, a small molecular subset within an aggressive malignancy with <15% five-year survival. Orphan ...

SAN DIEGO--(BUSINESS WIRE)--Curebound, a philanthropic organization that fundraises and invests in innovative cancer research, awarded 17 grants in December for a total of $8.25 million in funding to ...

Over the last 12 months, PanCAN stood in strong opposition to the administration’s threats to severely reduce federal funding ...

LOS ANGELES – Oct. 15, 2024 – Stand Up To Cancer® (SU2C) today announced grants to several teams of leading cancer investigators in support of cutting-edge research in a variety of cancers including ...

As a projected 10,000 Mainers are diagnosed with cancer this year, the Maine Cancer Foundation has awarded $550,840 in grants to four organizations with initiatives to help cancer patients navigate ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. STATE — Maine Cancer Foundation recently awarded four capacity-building ...

The Rally Foundation for Childhood Cancer Research, founded by Dean Crowe, has provided $50.5 million in support to ...

Seven Maine organizations will share $316,000 grants from the Maine Cancer Foundation for cancer prevention efforts across the state. Cancer remains a leading cause of death in Maine, affecting ...